Medifast, Inc. · Consumer Staples · Food Products
As of 2026-06-26, Medifast, Inc. (MED) has a 3-month relative strength percentile of 56 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47 (Neutral). Sector: Consumer Staples, ranked 8 of 11. Average daily range 4.0%, relative volume 7.17×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
56 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
MED is held by 3 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $3M notional. Top 3 carry $7M.
Top 3 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $3M |
| IWMiShares Russell 2000 ETF | 0.00% | $3M |
| VXFVanguard Extended Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MED Jan avg: -6.46% median: -7.14% win: 25% σ: 11.00% n: 4 2022-04-12 → 2026-05-29 | MED Feb avg: -10.63% median: -8.24% win: 25% σ: 11.46% n: 4 2022-04-12 → 2026-05-29 | MED Mar avg: -5.33% median: -5.27% win: 0% σ: 1.90% n: 4 2022-04-12 → 2026-05-29 | MED Apr avg: -7.51% median: -2.52% win: 20% σ: 13.23% n: 5 2022-04-12 → 2026-05-29 | MED May avg: -0.96% median: -6.50% win: 40% σ: 11.86% n: 5 2022-04-12 → 2026-05-29 | MED Jun avg: 2.50% median: 4.06% win: 50% σ: 13.76% n: 4 2022-04-12 → 2026-05-29 (current) | MED Jul avg: 0.56% median: -0.74% win: 50% σ: 7.33% n: 4 2022-04-12 → 2026-05-29 | MED Aug avg: -14.32% median: -16.89% win: 25% σ: 11.53% n: 4 2022-04-12 → 2026-05-29 | MED Sep avg: -5.72% median: -6.91% win: 25% σ: 8.36% n: 4 2022-04-12 → 2026-05-29 | MED Oct avg: -3.92% median: -5.79% win: 25% σ: 8.59% n: 4 2022-04-12 → 2026-05-29 | MED Nov avg: 0.50% median: 1.50% win: 50% σ: 8.18% n: 4 2022-04-12 → 2026-05-29 | MED Dec avg: -5.07% median: -5.57% win: 25% σ: 5.37% n: 4 2022-04-12 → 2026-05-29 |